| Name | Title | Contact Details |
|---|
Relmada Therapeutics, Inc. is a clinical stage, private biopharmaceutical company with a diversified portfolio of four products and a deep early stage pipeline for the treatment of pain. Relmada’s strategy focuses on two complementary pillars: the improvement of proven drug candidates with novel delivery methods and pharmaceutical compositions and the development of d-methadone as an innovative NMDA (N-Methyl-D-aspartate) inhibitor platform. The Company is currently developing several drug candidates including: LevoCap ER, its abuse resistant, once–a-day sustained release dosage form of the opioid analgesic levorphanol; d-methadone, the NDMA receptor antagonist for diabetic painful neuropathy (DPN); BuCap, its oral dosage form of the opioid analgesic buprenorphine; MepiGel, its FDA Orphan Drug designated topical formulation of the local anesthetic mepivacaine.
MD Care Inc is a Los Alamitos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioStorage Technologies Inc is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Colonial Manors Of Custer is a Custer, SD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Champion Nutrition Inc is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.